This page contains press release content distributed by XPR Media. Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content.

Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease

Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease

CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Spikevax®, the Company’s COVID-19 vaccine, in children 6 months through 11 years of age who are at increased risk for COVID-19 disease. The Company’s COVID-19 vaccine, mRNA-1273, was previously available for pediatric populations under Emergency Use Authorization (EUA).

“COVID-19 continues to pose a significant potential threat to children, especially those with underlying medical conditions. Vaccination can be an important tool for protecting our youngest against severe disease and hospitalization,” said Stéphane Bancel, Chief Executive Officer of Moderna. “We appreciate the FDA’s diligent scientific review and approval of Spikevax for pediatric populations at increased risk for COVID-19 disease.”

Moderna expects to have its updated Spikevax vaccine available for eligible populations in the U.S. for the 2025-2026 respiratory virus season.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Spikevax® is a registered trademark of Moderna.

INDICATION

SPIKEVAX (COVID-19 Vaccine, mRNA) is a vaccine to protect you against COVID-19. SPIKEVAX is for people who are:

  • 65 years of age and older, or

  • 6 months through 64 years of age at high risk for severe COVID-19.

Vaccination with SPIKEVAX may not protect all people who receive the vaccine.

IMPORTANT SAFETY INFORMATION

You or your child should not get SPIKEVAX if you had a severe allergic reaction after a previous dose of SPIKEVAX or any Moderna COVID-19 vaccine or to any ingredient in these vaccines.

What are the risks of SPIKEVAX?

There is a very small chance that SPIKEVAX could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to 1 hour after getting a dose of SPIKEVAX. For this reason, the healthcare provider may ask you or your child to stay for a short time at the place where you or your child received your vaccine. Signs of a severe allergic reaction can include:

  • Trouble breathing

  • Swelling of your face and throat

  • A fast heartbeat

  • A rash all over your body

  • Dizziness and weakness

  • Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) have occurred in some people who have received mRNA COVID-19 vaccines. Myocarditis and pericarditis following mRNA COVID-19 vaccines have occurred most commonly in males 12 years through 24 years of age. You should seek medical attention right away if you or your child has any of the following symptoms after receiving Spikevax, particularly during the 2 weeks after receiving a dose of the vaccine: chest pain, shortness of breath, feelings of having a fast-beating, fluttering, or pounding heart. Additional symptoms in children may include fainting, irritability, poor feeding, lack of energy, vomiting, pain in the abdomen, or cool, pale skin.

Other side effects that have been reported include:

  • Injection site reactions: pain, tenderness and swelling of the lymph nodes in the same arm of the injection or in the groin, swelling (hardness), and redness

  • General side effects: fatigue, headache, muscle pain, joint pain, chills, nausea and vomiting, fever, rash, irritability/crying, sleepiness, and loss of appetite.

  • Fainting and febrile seizures (convulsions during a fever) were also reported

Tell the healthcare provider about all of your or your child’s medical conditions, including if you or your child:

  • have any allergies

  • had a severe allergic reaction after receiving a previous dose of any COVID-19 vaccine

  • have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining outside the heart)

  • have a fever

  • have a bleeding disorder or are on a blood thinner

  • are immunocompromised or on a medicine that affects your immune system

  • are pregnant or plan to become pregnant

  • are breastfeeding

  • have received any other COVID-19 vaccine

  • have ever fainted in association with an injection

These may not be all the possible side effects of SPIKEVAX. Ask your healthcare provider about any side effects that concern you. You may report side effects to Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 or http://vaers.hhs.gov.

Please see the SPIKEVAX Full Prescribing Information.

Moderna Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding the availability of an updated Spikevax vaccine for eligible populations in the U.S. for the 2025-2026 respiratory virus season. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.

Moderna Contacts

Media:
Chris Ridley
Head of Global Media Relations
+1 617-800-3651
Chris.Ridley@modernatx.com

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
+1 617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@xpr.media

Dr. Demetris Stavrou and the European Institute of Plastic Surgery in Limassol Announce Upcoming Launch of Advanced Tummy Tuck 360 Procedure

Dr. Demetris Stavrou and the European Institute of Plastic Surgery in Limassol Announce Upcoming Launch of Advanced Tummy Tuck 360 Procedure

LIMASSOL, CYPRUS – July 11, 2025 – The European Institute of Plastic Surgery (EIPS), under the direction of distinguished and board-certified plastic surgeon Dr. Demetris…

July 10, 2025

Convert Peak Launches Phonetix A.I. to Transform Roofing Sales with Voice-Driven Automation

Convert Peak Launches Phonetix A.I. to Transform Roofing Sales with Voice-Driven Automation

New Voice AI Assistant Gives Roofing Contractors a Competitive Edge in Storm-Damage Sales SCOTTSDALE, AZ / ACCESS Newswire / July 10, 2025 / Roofing contractors…

July 10, 2025

Terra Innovatum to Participate in Upcoming H.C. Wainwright Virtual Conference on July 15, 2025

Terra Innovatum to Participate in Upcoming H.C. Wainwright Virtual Conference on July 15, 2025

NEW YORK, NY and AUSTIN, TX / ACCESS Newswire / July 10, 2025 / Terra Innovatum Srl (“Terra Innovatum,” or the “Company”), a developer of…

July 10, 2025

Legacy in Motion: Preparing the Next Generation at Bradley Wealth

Legacy in Motion: Preparing the Next Generation at Bradley Wealth

SCOTTSDALE, AZ / ACCESS Newswire / July 10, 2025 / Michael Bradley has spent more than 30 years building one of the most trusted independent…

July 10, 2025

Qamar Zaman Starts Google SEO Advocacy — FREE for Grand Cayman Business Owners | Coffee With Q Podcast

Qamar Zaman Starts Google SEO Advocacy — FREE for Grand Cayman Business Owners | Coffee With Q Podcast

George Town, Cayman Islands / Storyteller / Jul 06, 2025 / A local podcaster is transforming how Grand Cayman businesses approach digital marketing and online…

July 10, 2025

Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs

Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs

Company strategy: In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally approved for CID, to regulatory approval and commercialization…

July 10, 2025

Abacus Raises $6.6M Seed Round to Build Agentic CPA Assistants for the Modern Accounting Firm

Abacus Raises $6.6M Seed Round to Build Agentic CPA Assistants for the Modern Accounting Firm

Menlo Ventures leads round backing intelligent assistants that help tax firms scale amid rising workloads and shrinking headcount. SAN FRANCISCO, CA / ACCESS Newswire /…

July 10, 2025

Brenmiller Energy Releases Annual ESG Report Highlighting Commercial Expansion, Carbon Tracking, and Sustainable Innovation

Brenmiller Energy Releases Annual ESG Report Highlighting Commercial Expansion, Carbon Tracking, and Sustainable Innovation

Report details progress in Environmental, Social, and Governance priorities and strengthens investor transparency The full ESG report is available: HERE To view Brenmiller’s latest investor…

July 10, 2025

Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease

Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease

Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19…

July 10, 2025

Arrive AI selects Synoptek as a Strategic IT Partner to Power Global Expansion

Arrive AI selects Synoptek as a Strategic IT Partner to Power Global Expansion

INDIANAPOLIS, IN AND COSTA MESA, CA / ACCESS Newswire / July 10, 2025 / Arrive AI (NASDAQ:ARAI) – a pioneering autonomous delivery network anchored by…

July 10, 2025

Stellar Painting’s Commercial Painting Fort Worth Services Drive Business Growth

Stellar Painting’s Commercial Painting Fort Worth Services Drive Business Growth

A recently completed commercial renovation in Fort Worth is drawing attention for its precise coordination, durable materials, and design-focused execution. Led by the experienced team…

July 10, 2025

Electrovaya Achieves UL2580 Certification for Over 400 Next-Generation Lithium-Ion Battery Models

Electrovaya Achieves UL2580 Certification for Over 400 Next-Generation Lithium-Ion Battery Models

Latest battery systems feature enhanced performance and include 54Ah ceramic cell to be mass produced in Jamestown, NY Passed the most stringent safety testing in…

July 10, 2025

Unusual Machines Expands Leadership Team with Appointment of Tim Manton as Corporate Controller

Unusual Machines Expands Leadership Team with Appointment of Tim Manton as Corporate Controller

New hire supports operational scale-up and financial infrastructure as company ramps U.S. motor manufacturing ORLANDO, FLORIDA / ACCESS Newswire / July 9, 2025 / Unusual…

July 9, 2025

Mitolyn Reviews: Dangerous Hype Or The Breakthrough Doctors Can’t Ignore In 2025?

Mitolyn Reviews: Dangerous Hype Or The Breakthrough Doctors Can’t Ignore In 2025?

Discover the real science behind Mitolyn, the metabolic complaints it’s silencing, verified 90-day results, and why thousands of Americans are shifting from caffeine-based fat burners…

July 9, 2025

Experience the Best Chow Mein Combination in Las Vegas at Kung Fu Thai & Chinese Restaurant

Experience the Best Chow Mein Combination in Las Vegas at Kung Fu Thai & Chinese Restaurant

Kung Fu Thai & Chinese Restaurant has introduced the “Best Chow Mein Combination in Las Vegas.” This new menu item showcases the restaurant’s commitment to…

July 9, 2025

Nancy’s Plumbing: Antioch’s Trusted, Family-Owned Plumbing Company Offering Reliable Service

Nancy’s Plumbing: Antioch’s Trusted, Family-Owned Plumbing Company Offering Reliable Service

Nancy’s Plumbing, a family-owned and operated plumbing company based in Antioch, CA, continues to gain recognition as a reliable, affordable, and trusted source for professional…

July 9, 2025

Interactive Strength Inc. (Nasdaq: TRNR) Receives “Buy” Rating and $15 Price Target in Maxim Group Research Initiation

Interactive Strength Inc. (Nasdaq: TRNR) Receives “Buy” Rating and $15 Price Target in Maxim Group Research Initiation

First comprehensive sell-side report on TRNR cites more than 800% growth in expected 2025 revenue Valuation driven by stock-for-stock M&A model and potential crypto-treasury upside…

July 9, 2025

The Edward Pierce Center for Autism Inc Launches Initiatives to Expand Critical Services for Underserved Communities

The Edward Pierce Center for Autism Inc Launches Initiatives to Expand Critical Services for Underserved Communities

Arlington, Texas / Storyteller / Jul 09, 2025 / The Edward Pierce Center for Autism Inc. (EPCA), a nonprofit organization founded by Tracy Pierce, PhD,…

July 9, 2025

Certidox Adds AI-Powered QR Code Analysis to Free App for Document and Link Authentication

Certidox Adds AI-Powered QR Code Analysis to Free App for Document and Link Authentication

Certidox releases a major update to its free mobile app, adding AI-powered QR code analysis to detect phishing and fraud. The platform lets users instantly…

July 9, 2025

Preston Spire Taps Dustin Black to Supercharge “Good Wins” Creative Philosophy

Preston Spire Taps Dustin Black to Supercharge “Good Wins” Creative Philosophy

25-Year Industry Veteran to Guide Agency Through AI Evolution with “Culture of Curiosity” and Collaborative Leadership MINNEAPOLIS, MN / ACCESS Newswire / July 9, 2025…

July 9, 2025

HepatoBurn Reviews: What Are Doctors and Nutritionists Really Saying About This Formula (Latest Research)?

HepatoBurn Reviews: What Are Doctors and Nutritionists Really Saying About This Formula (Latest Research)?

Digging Into HepatoBurn Reviews, Ingredients, Side Effects & Why This Liver-Focused Metabolism Formula Is Dominating 2025 Consumer Reports DENVER, CO / ACCESS Newswire / July…

July 9, 2025

Locally Owned, Physician-Led: A New Standard in Mobile Wound Care for South Carolina

Locally Owned, Physician-Led: A New Standard in Mobile Wound Care for South Carolina

Skip the Clinic – New Mobile Wound Care Service Offers Cutting-Edge Treatment at Home GREENVILLE, SOUTH CAROLINA / ACCESS Newswire / July 9, 2025 /…

July 9, 2025

Agassi Sports Entertainment Engages IBM to Help Elevate Racquet Sports Experience

Agassi Sports Entertainment Engages IBM to Help Elevate Racquet Sports Experience

LAS VEGAS, NV / ACCESS Newswire / July 9, 2025 / Agassi Sports Entertainment Corp. (OTC PINK:AASP), an emerging leader in sports entertainment and innovation,…

July 9, 2025

Augmentus Raises $11M to Scale Physical AI for High-Mix, Complex Robotic Surface Finishing and Welding

Augmentus Raises $11M to Scale Physical AI for High-Mix, Complex Robotic Surface Finishing and Welding

SINGAPORE, SG / ACCESS Newswire / July 9, 2025 / Augmentus, the developer of an intelligent no-code robotics solution, announced today that it has raised…

July 9, 2025

Crypto Tax Enforcement Is Back – Clear Start Tax Urges Traders to Avoid Costly Mistakes and Stay Compliant

Crypto Tax Enforcement Is Back – Clear Start Tax Urges Traders to Avoid Costly Mistakes and Stay Compliant

IRS letters targeting digital asset holders are on the rise – Clear Start Tax outlines what crypto traders need to know to protect themselves. IRVINE,…

July 9, 2025

Ahead of World IVF Day, HRC Fertility Launches Innovative Clinical Trial with Gameto for More Approachable IVF

Ahead of World IVF Day, HRC Fertility Launches Innovative Clinical Trial with Gameto for More Approachable IVF

LOS ANGELES, CA / ACCESS Newswire / July 9, 2025 / HRC Fertility is proud to announce its participation in a groundbreaking clinical trial evaluating…

July 9, 2025

AGFA HealthCare Achieves HITRUST I1 Certification, Demonstrating Its Commitment to and Compliance With Data Protection Standards, and Protecting Against Cybersecurity Threats

AGFA HealthCare Achieves HITRUST I1 Certification, Demonstrating Its Commitment to and Compliance With Data Protection Standards, and Protecting Against Cybersecurity Threats

HITRUST certification validates that AGFA HealthCare is operating using leading security practices to protect sensitive information. MORTSEL, BE / ACCESS Newswire / July 9, 2025…

July 9, 2025

Sarkinen Industrial Pipelining Unveils Robotic Pipeline Cutting for Eco-Friendly Solutions

Sarkinen Industrial Pipelining Unveils Robotic Pipeline Cutting for Eco-Friendly Solutions

Sarkinen Industrial Pipelining has rolled out a new environmentally friendly innovation in its pipe maintenance services. This new feature helps meet the rising demand for…

July 8, 2025

North Shore Uranium Engages Investing News Network

North Shore Uranium Engages Investing News Network

VANCOUVER, BC / ACCESS Newswire / July 8, 2025 / North Shore Uranium Ltd. (TSX-V:NSU) (“North Shore” or the “Company“) is pleased to announce that…

July 8, 2025

New to The Street Announces Media Coverage of BitMine Immersion Technologies Inc., Including NewsOut Video PR Integration

New to The Street Announces Media Coverage of BitMine Immersion Technologies Inc., Including NewsOut Video PR Integration

NEW YORK CITY, NEW YORK / ACCESS Newswire / July 8, 2025 / New to The Street, the award-winning national TV business show airing weekly…

July 8, 2025

Curative Health Insurance Company’s Financial Strength Rating Affirmed by AM Best for Third Consecutive Year

Curative Health Insurance Company’s Financial Strength Rating Affirmed by AM Best for Third Consecutive Year

AUSTIN, TX / ACCESS Newswire / July 8, 2025 / Curative Insurance Company is proud to announce that AM Best, the global credit rating agency…

July 8, 2025

PrivateJet.com Launches a New Era in On-Demand Luxury Air Travel

PrivateJet.com Launches a New Era in On-Demand Luxury Air Travel

MIAMI, FL / ACCESS Newswire / July 8, 2025 / PrivateJet.com (PrivateJet.com LLC), the leading domain in private aviation, has officially launched. The platform guides…

July 8, 2025

Skip Barber Racing School to Build First-Ever Racing Resort in Ixtapan de la Sal, Mexico

Skip Barber Racing School to Build First-Ever Racing Resort in Ixtapan de la Sal, Mexico

NEW YORK, NY AND IXTAPAN DE LA SAL, MEXICO / ACCESS Newswire / July 8, 2025 / Skip Barber Racing School (SBRS), widely regarded as…

July 8, 2025

CoTec Investment Mkango and Hypromag Announces First Production from Commercial-Scale Recycled Rare Earth Alloy Production in the UK

CoTec Investment Mkango and Hypromag Announces First Production from Commercial-Scale Recycled Rare Earth Alloy Production in the UK

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / July 8, 2025 / CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) (“CoTec” or the “Company”) is pleased to note that Mkango…

July 8, 2025

Mobile Global Esports (MGAM) Launches First Dominus Fantasy Baseball League and Begins Generating Revenue

Mobile Global Esports (MGAM) Launches First Dominus Fantasy Baseball League and Begins Generating Revenue

New leadership, a sharpened focus, and the monetization of proprietary technology mark a transformational milestone for the company. WESTPORT, CT / ACCESS Newswire / July…

July 8, 2025

Jonathan Misura Urges Young Athletes to Embrace Failure and Discipline

Jonathan Misura Urges Young Athletes to Embrace Failure and Discipline

College Pitcher Shares Lessons on Resilience and Hard Work in New Feature Interview MILLTOWN, NJ / ACCESS Newswire / July 8, 2025 / Jonathan Misura,…

July 8, 2025

Xenetic Biosciences, Inc. Announces Update from Collaboration Partner of  First Patient Dosed in Exploratory Clinical Study of DNase I in Combination with FOLFIRINOX for the First Line Treatment of Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

Xenetic Biosciences, Inc. Announces Update from Collaboration Partner of First Patient Dosed in Exploratory Clinical Study of DNase I in Combination with FOLFIRINOX for the First Line Treatment of Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

Investigator initiated exploratory clinical study being conducted in Israel pursuant to agreement with collaboration partner, PeriNess Company evaluating systemic recombinant human DNase I (DNase I)…

July 8, 2025

Brenmiller to Launch New bGen(TM) Thermal Energy Storage System for Nuclear Small Modular Reactors (SMRs) – Powering the Nuclear Resurgence

Brenmiller to Launch New bGen(TM) Thermal Energy Storage System for Nuclear Small Modular Reactors (SMRs) – Powering the Nuclear Resurgence

Nuclear power is increasingly seen as the next-generation source to support the energy demands of computing and AI infrastructure while boosting energy independence and decarbonizing…

July 8, 2025

Monogram Technologies Announces the Mandatory Conversion of 8.00% Series D Convertible Cumulative Preferred Stock

Monogram Technologies Announces the Mandatory Conversion of 8.00% Series D Convertible Cumulative Preferred Stock

AUSTIN, TEXAS / ACCESS Newswire / July 8, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) (“Monogram” or the “Company”), an AI-driven robotics company revolutionizing orthopedic surgery,…

July 8, 2025

LQR House Announces Strategic Marketing Cooperation with Montauk Distilling Co. for Cinnamon Flavored Rum

LQR House Announces Strategic Marketing Cooperation with Montauk Distilling Co. for Cinnamon Flavored Rum

Cooperation expected to drive targeted awareness and ecommerce sales to the brand through LQR House’s proprietary marketing channels MIAMI BEACH, FLORIDA / ACCESS Newswire /…

July 8, 2025